These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 34850014)

  • 21. Progression to type 1 diabetes and autoantibody positivity in relation to HLA-risk genotypes in children participating in the ABIS study.
    Gullstrand C; Wahlberg J; Ilonen J; Vaarala O; Ludvigsson J
    Pediatr Diabetes; 2008 Jun; 9(3 Pt 1):182-90. PubMed ID: 18331414
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic risk markers related to diabetes-associated autoantibodies in young patients with type 1 diabetes in berlin, Germany.
    Kordonouri O; Hartmann R; Charpentier N; Knip M; Danne T; Ilonen J
    Exp Clin Endocrinol Diabetes; 2010 Apr; 118(4):245-9. PubMed ID: 20140847
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prediction of autoantibody positivity and progression to type 1 diabetes: Diabetes Autoimmunity Study in the Young (DAISY).
    Barker JM; Barriga KJ; Yu L; Miao D; Erlich HA; Norris JM; Eisenbarth GS; Rewers M;
    J Clin Endocrinol Metab; 2004 Aug; 89(8):3896-902. PubMed ID: 15292324
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proinsulin:C-peptide ratio trajectories over time in relatives at increased risk of progression to type 1 diabetes.
    Triolo TM; Pyle L; Seligova S; Yu L; Simmons K; Gottlieb P; Evans-Molina C; Steck AK
    J Transl Autoimmun; 2021; 4():100089. PubMed ID: 33748733
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Type 1 diabetes risk for human leukocyte antigen (HLA)-DR3 haplotypes depends on genotypic context: association of DPB1 and HLA class I loci among DR3- and DR4-matched Italian patients and controls.
    Noble JA; Martin A; Valdes AM; Lane JA; Galgani A; Petrone A; Lorini R; Pozzilli P; Buzzetti R; Erlich HA
    Hum Immunol; 2008; 69(4-5):291-300. PubMed ID: 18486765
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-affinity ZnT8 Autoantibodies by Electrochemiluminescence Assay Improve Risk Prediction for Type 1 Diabetes.
    Jia X; He L; Miao D; Waugh K; Rasmussen CG; Dong F; Steck AK; Rewers M; Yu L
    J Clin Endocrinol Metab; 2021 Nov; 106(12):3455-3463. PubMed ID: 34343303
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multiplex agglutination-PCR (ADAP) autoantibody assays compared to radiobinding autoantibodies in type 1 diabetes and celiac disease.
    Lind A; de Jesus Cortez F; Ramelius A; Bennet R; Robinson PV; Seftel D; Gebhart D; Tandel D; Maziarz M; Agardh D; Larsson HE; Lundgren M; Tsai CT; Lernmark Å
    J Immunol Methods; 2022 Jul; 506():113265. PubMed ID: 35358496
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A quarter of patients with type 1 diabetes have co-existing non-islet autoimmunity: the findings of a UK population-based family study.
    Kozhakhmetova A; Wyatt RC; Caygill C; Williams C; Long AE; Chandler K; Aitken RJ; Wenzlau JM; Davidson HW; Gillespie KM; Williams AJK
    Clin Exp Immunol; 2018 Jun; 192(3):251-258. PubMed ID: 29431870
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Associations between deduced first islet specific autoantibody with sex, age at diagnosis and genetic risk factors in young children with type 1 diabetes.
    Ilonen J; Laine AP; Kiviniemi M; Härkönen T; Lempainen J; Knip M;
    Pediatr Diabetes; 2022 Sep; 23(6):693-702. PubMed ID: 35403376
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Type 1 diabetes in the Spanish population: additional factors to class II HLA-DR3 and -DR4.
    Urcelay E; Santiago JL; de la Calle H; Martínez A; Méndez J; Ibarra JM; Maluenda C; Fernández-Arquero M; de la Concha EG
    BMC Genomics; 2005 Apr; 6():56. PubMed ID: 15842729
    [TBL] [Abstract][Full Text] [Related]  

  • 31. International Workshop on Lessons From Animal Models for Human Type 1 Diabetes: identification of insulin but not glutamic acid decarboxylase or IA-2 as specific autoantigens of humoral autoimmunity in nonobese diabetic mice.
    Bonifacio E; Atkinson M; Eisenbarth G; Serreze D; Kay TW; Lee-Chan E; Singh B
    Diabetes; 2001 Nov; 50(11):2451-8. PubMed ID: 11679421
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glutamic acid decarboxylase antibodies in relation to other autoantibodies and genetic risk markers in children with newly diagnosed insulin-dependent diabetes. Childhood Diabetes in Finland Study Group.
    Sabbah E; Kulmala P; Veijola R; Vähäsalo P; Karjalainen J; Tuomilehto-Wolf E; Akerblom HK; Knip M
    J Clin Endocrinol Metab; 1996 Jul; 81(7):2455-9. PubMed ID: 8675560
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Possible human leukocyte antigen-mediated genetic interaction between type 1 and type 2 Diabetes.
    Li H; Lindholm E; Almgren P; Gustafsson A; Forsblom C; Groop L; Tuomi T
    J Clin Endocrinol Metab; 2001 Feb; 86(2):574-82. PubMed ID: 11158011
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Specific association of HLA-DR4 with increased prevalence and level of insulin autoantibodies in first-degree relatives of patients with type I diabetes.
    Ziegler R; Alper CA; Awdeh ZL; Castano L; Brink SJ; Soeldner JS; Jackson RA; Eisenbarth GS
    Diabetes; 1991 Jun; 40(6):709-14. PubMed ID: 2040387
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The relationship between islet autoantibody status and the genetic risk of type 1 diabetes in adult-onset type 1 diabetes.
    Thomas NJ; Walkey HC; Kaur A; Misra S; Oliver NS; Colclough K; Weedon MN; Johnston DG; Hattersley AT; Patel KA
    Diabetologia; 2023 Feb; 66(2):310-320. PubMed ID: 36355183
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum titres of anti-glutamic acid decarboxylase-65 and anti-IA-2 autoantibodies are associated with different immunoregulatory milieu in newly diagnosed type 1 diabetes patients.
    Gabbay MA; Sato MN; Duarte AJ; Dib SA
    Clin Exp Immunol; 2012 Apr; 168(1):60-7. PubMed ID: 22385239
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The 6 year incidence of diabetes-associated autoantibodies in genetically at-risk children: the TEDDY study.
    Krischer JP; Lynch KF; Schatz DA; Ilonen J; Lernmark Å; Hagopian WA; Rewers MJ; She JX; Simell OG; Toppari J; Ziegler AG; Akolkar B; Bonifacio E;
    Diabetologia; 2015 May; 58(5):980-7. PubMed ID: 25660258
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Millennium award recipient contribution. Identification of children with early onset and high incidence of anti-islet autoantibodies.
    Robles DT; Eisenbarth GS; Wang T; Erlich HA; Bugawan TL; Babu SR; Barriga K; Norris JM; Hoffman M; Klingensmith G; Yu L; Rewers M;
    Clin Immunol; 2002 Mar; 102(3):217-24. PubMed ID: 11890708
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Two subsets of HLA-DQA1 alleles mark phenotypic variation in levels of insulin autoantibodies in first degree relatives at risk for insulin-dependent diabetes.
    Pugliese A; Bugawan T; Moromisato R; Awdeh ZL; Alper CA; Jackson RA; Erlich HA; Eisenbarth GS
    J Clin Invest; 1994 Jun; 93(6):2447-52. PubMed ID: 8200980
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transcomplementation of HLA DQA1-DQB1 in DR3/DR4 and DR3/DR9 heterozygotes and IDDM in Taiwanese families.
    Chuang LM; Wu HP; Tsai WY; Lin BJ; Tai TY
    Diabetes Care; 1995 Nov; 18(11):1483-6. PubMed ID: 8722074
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.